Efe, C. Et Al. 2018. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis. DIGESTIVE DISEASES AND SCIENCES , vol.63, no.5 , 1348-1354.

Efe, C., Al Taii, H., Ytting, H., Aehling, N., Bhanji, R. A. , Hagstrom, H., ... PÜRNAK, T.(2018). Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis. DIGESTIVE DISEASES AND SCIENCES , vol.63, no.5, 1348-1354.

Efe, Cumali Et Al. "Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis," DIGESTIVE DISEASES AND SCIENCES , vol.63, no.5, 1348-1354, 2018

Efe, Cumali Et Al. "Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis." DIGESTIVE DISEASES AND SCIENCES , vol.63, no.5, pp.1348-1354, 2018

Efe, C. Et Al. (2018) . "Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis." DIGESTIVE DISEASES AND SCIENCES , vol.63, no.5, pp.1348-1354.

@article{article, author={Cumali Efe Et Al. }, title={Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis}, journal={DIGESTIVE DISEASES AND SCIENCES}, year=2018, pages={1348-1354} }